ArticleOncology letters2018

Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia.

Kei Kushitani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.